# Vaccine and Treatment Evaluation Unit: Phase I Clinical Trial to Evaluate a Hepatitis E Vaccine

> **NIH NIH N01** · EMORY UNIVERSITY · 2021 · $2,714

## Abstract

This program is comprised of a consortium of individual contracts within academic centers and organizations that provide a ready resource for the design and conduct of clinical trials to evaluate promising products to combat infectious diseases. In general, products will be evaluated in normal healthy populations; however, access to special populations  is also available.

## Key facts

- **NIH application ID:** 10453426
- **Project number:** 272201300018I-P00003-27200022-1
- **Recipient organization:** EMORY UNIVERSITY
- **Principal Investigator:** Mark Joseph Mulligan
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $2,714
- **Award type:** —
- **Project period:** 2018-04-01 → 2021-09-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10453426

## Citation

> US National Institutes of Health, RePORTER application 10453426, Vaccine and Treatment Evaluation Unit: Phase I Clinical Trial to Evaluate a Hepatitis E Vaccine (272201300018I-P00003-27200022-1). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/10453426. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*